Michiel van Esdonk

23PUBLICATIONS
48CO-AUTHORS
Toxicology (incl. clinical toxicology)PharmacogenomicsMolecular medicineLarge and complex data theoryPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 21, 2025
Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis.

Marije E Otto, Katelijne V van der Heijden, Jan W Schoones

|Jan 21, 2025
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis.

K V van der Heijden, M E Otto, J W Schoones

|Jan 15, 2025
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.

Marije E Otto, Katelijne V van der Heijden, Jan W Schoones

|Dec 09, 2024
Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

Titia Q Ruijs, Catherine M K E de Cuba, Jules A A C Heuberger

|Nov 22, 2023
A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation.

Christina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende

|Aug 08, 2023
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale.

Marije E Otto, Kirsten R Bergmann, Marieke L de Kam

Pageof 4

Frequent Collaborators

4 joint publications

Marije E Otto

4 joint publications

Adam F Cohen

4 joint publications

Jasper Stevens

3 joint publications

Katelijne V van der Heijden